Search results for "illness"

showing 10 items of 1529 documents

Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function

2010

Aim: Left ventricular hypertrophy (LVH) is an independent predictor of cardiovascular (CV) morbidity and mortality. The aim of the present study was to evaluate the relationship between LV mass and mild-to-moderate renal dysfunction in a group of non-diabetic hypertensives, free of CV diseases, participating in the Renal Dysfunction in Hypertension (REDHY) study. Methods: Patients with diabetes, a body mass index (BMI) of more than 35 kg/m 2 , secondary hypertension, CV diseases and a glomerular filtration rate (GFR) of less than 30 mL/min per 1.73 m 2 were excluded. The final sample included 455 patients, who underwent echocardiographic examination and ambulatory blood pressure monitoring.…

AdultMalemedicine.medical_specialtyAmbulatory blood pressureBody Surface AreaHeart VentriclesPopulationSecondary hypertensionRenal functionBlood PressureKidneyurologic and male genital diseasesLeft ventricular hypertrophyRisk AssessmentSeverity of Illness IndexRisk FactorsInternal medicinemedicineHumansHypertension Glomerular filtration rate Chronic kidney disease Cardiovascular disease Left ventricular mass Left ventricular hypertrophy.educationBody surface areaeducation.field_of_studyChi-Square Distributionbusiness.industryConfounding Factors EpidemiologicGeneral MedicineBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseBody HeightCross-Sectional StudiesLogistic ModelsBlood pressureItalyEchocardiographyNephrologyHypertensionCardiologyFemaleHypertrophy Left VentricularKidney DiseasesbusinessGlomerular Filtration RateKidney diseaseNephrology
researchProduct

Value of Home Blood Pressures as Predictor of Target Organ Damage in Mild Arterial Hypertension

2002

Home blood pressure measurement has gained increasing importance for the management of hypertensive patients. The aim of our study was to compare levels of clinic (CBP), ambulatory (ABP), and home blood pressure (HBP) measurements, and their relationships with various indexes of target organ damage in I-II grade essential hypertension.Thirty-eight essential hypertensives underwent evaluation of clinic, ambulatory and home blood pressures. Each patient recorded HBP for 2 days with a digital BP monitor three times daily, the first time on the same day during which ABP monitoring was simultaneously performed. Moreover, in all subjects electrocardiogram recording, echocardiographic study, micro…

AdultMalemedicine.medical_specialtyAmbulatory blood pressureEpidemiologyMultiple Organ FailureStatistics as TopicDiastoleAmbulatory Care FacilitiesSeverity of Illness IndexPrehypertensionPredictive Value of TestsInternal medicineAlbuminuriaHumansMedicinebusiness.industryBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseTarget organ damageSurgeryBlood pressureItalyHypertensionAmbulatoryCardiologyFemaleHypertrophy Left VentricularMicroalbuminuriaCardiology and Cardiovascular MedicinebusinessEuropean Journal of Cardiovascular Prevention & Rehabilitation
researchProduct

Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis

2008

Psoriasis and psoriatic arthritis are common diseases associated with considerable morbidity and disability. Their pathophysiology comprises similar processes leading to inflammation of skin, entheses, and joints. Although traditional systemic agents can be effective, their use may be limited by lack of efficacy and concerns regarding adverse effects. The objective of this study was to assess the efficacy and safety of adalimumab, a fully human antitumor necrosis factor (anti-TNF) monoclonal antibody, over 16 weeks. The present authors report their personal experience in 15 patients with severe plaque psoriasis and psoriatic arthritis, refractory to other treatments, in which a decisive reg…

AdultMalemedicine.medical_specialtyAnti-Inflammatory AgentsArthritisDermatologyAntibodies Monoclonal HumanizedSeverity of Illness IndexPsoriasis Psoriatic ArthritisPsoriatic arthritisPsoriasisSeverity of illnessSettore MED/35 - Malattie Cutanee E VenereemedicineAdalimumabHumansPsoriasisAdverse effectTumor Necrosis Factor-alphabusiness.industryArthritis PsoriaticAdalimumabAntibodies MonoclonalGeneral MedicineMiddle Agedmedicine.diseaseDermatologyRadiographyClinical trialTreatment OutcomeMonoclonalFemalebusinessmedicine.drugDermatologic Therapy
researchProduct

Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic sy…

2010

Summary Background & aims Phytosterols (PS) lower LDLc, but their effect on metabolic syndrome (MetS) remains unknown. We evaluated whether low-fat milk enriched with PS improves cardiovascular risk factors in these patients. Methods A randomised parallel trial employing 24 moderate-hypercholesterolaemic MetS patients and consisting of two 3-month intervention phases. After a 3-month healthy diet, patients were divided into two intervention groups: diet (n = 10) and diet + PS (n = 14) (2 g/day). A control group of 24 moderate-hypercholesterolaemic patients without MetS (matched in age and BMI) underwent the same procedure. Results Neither dietary intervention nor enrichment of PS induced an…

AdultMalemedicine.medical_specialtyApolipoprotein BHomocysteineLipoproteinsHypercholesterolemiaPopulationCritical Care and Intensive Care MedicineSeverity of Illness IndexCholesterol Dietarychemistry.chemical_compoundRisk FactorsInternal medicinemedicineHumanseducationHypolipidemic AgentsMetabolic Syndromeeducation.field_of_studyNutrition and Dieteticsmedicine.diagnostic_testbiologybusiness.industryAnticholesteremic AgentsPhytosterolsMiddle Agedmedicine.diseaseSitosterolsCholesterolEndocrinologyIntestinal AbsorptionchemistryCardiovascular DiseasesSpainDietary SupplementsIntestinal cholesterol absorptionbiology.proteinFemaleMetabolic syndromebusinessLipid profileBody mass indexLipoproteinClinical Nutrition
researchProduct

Experimental evidence for a motivational origin of cognitive impairment in major depression.

2007

BackgroundDiagnostic criteria and empirical evidence support the existence of cognitive deficits in depression. However, depressed mood, loss of interest and low self-efficacy might influence cognitive performance.MethodGoal-setting instructions were used to promote motivation in depressed patients and control subjects during neuropsychological assessment. The resulting performance was compared with performance using standard instructions. Sixty in-patients with non-psychotic unipolar depression and 60 age- and education-matched healthy control subjects were assessed with standard neuropsychological tests [the Auditory Verbal Learning Test (AVLT), the Digit Symbol Test (DST), the Regensburg…

AdultMalemedicine.medical_specialtyAudiologyNeuropsychological TestsVerbal learningSeverity of Illness IndexSurveys and QuestionnairesmedicinePrevalenceVerbal fluency testHumansNeuropsychological assessmentPsychiatryApplied PsychologyDepression (differential diagnoses)Psychomotor learningDepressive Disorder MajorMotivationmedicine.diagnostic_testCognitive disorderNeuropsychologyCognitionVerbal Learningmedicine.diseaseSelf EfficacyPsychiatry and Mental healthFemalePsychomotor DisordersPsychologyCognition DisordersGoalsPsychological medicine
researchProduct

Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports

2017

Abstract Rationale: To report our experience on 7 patients (4 males and 3 females), affected by nonparaneoplastic Lambert–Eaton myasthenic syndrome, treated with 3,4-diaminopyridine phosphate (3,4-DAPP) either alone or in combination with other immunosuppressants or steroids. Patient concerns: Patients have been evaluated at specific timepoints (ie, baseline and last 5 year follow-up), with neurological examination, autoantibodies against presynaptic voltage-gated Cav2.1 (P/Q type) calcium ion channel (VGCC) dosage, neurophysiological evaluation focusing on the increased amplitude of the compound muscle action potential (cMAP) after maximum voluntary effort, quantitative myasthenia gravis (…

AdultMalemedicine.medical_specialtyAzathioprineNeurological examination030204 cardiovascular system & hematologySeverity of Illness Index5300nonparaneoplastic-Lambert–Eaton myasthenic syndrome03 medical and health sciences0302 clinical medicinePrednisoneInternal medicineSeverity of illnessActivities of Daily LivingAzathioprinemedicineHumansMuscle StrengthClinical Case Report4-AminopyridineAdverse effect34-diaminopyridine phosphate; nonparaneoplastic-Lambert-Eaton myasthenic syndrome; 4-Aminopyridine; Activities of Daily Living; Adult; Azathioprine; Drug Therapy Combination; Female; Humans; Immunosuppressive Agents; Lambert-Eaton Myasthenic Syndrome; Male; Middle Aged; Muscle Strength; Prednisone; Severity of Illness Index; Treatment Outcome; Medicine (all)medicine.diagnostic_testbusiness.industry34-diaminopyridine phosphateGeneral MedicineMiddle Agedmedicine.diseaseMyasthenia gravisLambert-Eaton Myasthenic SyndromeTreatment OutcomeConcomitantPrednisoneDrug Therapy CombinationFemaleAmifampridinebusinessLambert-Eaton myasthenic syndrome030217 neurology & neurosurgeryImmunosuppressive Agentsmedicine.drugResearch Article
researchProduct

Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory

2016

BackgroundFunctional remediation is a novel intervention with demonstrated efficacy at improving functional outcome in euthymic bipolar patients. However, in a previous trial no significant changes in neurocognitive measures were detected. The objective of the present analysis was to test the efficacy of this therapy in the enhancement of neuropsychological functions in a subgroup of neurocognitively impaired bipolar patients.MethodA total of 188 out of 239 DSM-IV euthymic bipolar patients performing below two standard deviations from the mean of normative data in any neurocognitive test were included in this subanalysis. Repeated-measures analyses of variance were conducted to assess the i…

AdultMalemedicine.medical_specialtyBipolar DisorderCognition disordersmedicine.medical_treatmenteducation.educational_degreePsychiatric rehabilitationRehabilitació de drogoaddictesNeuropsychological TestsPsychiatric RehabilitationAudiologyVerbal learningTrastorns de la cognició03 medical and health sciences0302 clinical medicinePatient Education as TopicMemorymedicinePsychoeducationHumansManic-depressive illnessBipolar disordereducationApplied PsychologyTrastorn bipolarNeuropsychologyMiddle AgedVerbal Learningmedicine.disease030227 psychiatryPsychiatry and Mental healthNarcotics addicts rehabilitationSchizophreniaMental RecallFemaleVerbal memoryCognition DisordersPsychologyNeurocognitive030217 neurology & neurosurgeryClinical psychology
researchProduct

Treatment nonadherence and neurocognitive impairment in bipolar disorder.

2009

OBJECTIVE: Little is known regarding the relationship between treatment adherence and residual cognitive dysfunction in euthymic bipolar disorder patients. This study aimed to investigate whether poor treatment adherence is associated with cognitive impairment in euthymic bipolar patients and whether other factors may be associated with both adherence and cognitive functioning. METHOD: Euthymic DSM-IV bipolar I or II disorder patients (N = 103: 61 with high levels of treatment adherence and 42 with poor treatment adherence) were assessed using a neuropsychological battery targeting attention, psychomotor speed, verbal memory, and executive functions and compared with 35 healthy controls of …

AdultMalemedicine.medical_specialtyBipolar DisorderComorbidityNeuropsychological TestsYoung Mania Rating ScaleVerbal learningSeverity of Illness IndexMemorymedicineHumansBipolar disorderPsychiatryPsychiatric Status Rating ScalesCognitive disorderHamilton Rating Scale for DepressionVerbal Learningmedicine.diseaseExecutive functionsDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthPatient ComplianceFemaleVerbal memoryPsychologyCognition DisordersLithium ChlorideNeurocognitivePsychomotor PerformanceClinical psychologyThe Journal of clinical psychiatry
researchProduct

Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder

2009

Abstract Background The relevance of persistent cognitive deficits to the pathogenesis and prognosis of bipolar disorders (BD) is understudied, and its translation into clinical practice has been limited by the absence of brief methods assessing cognitive status in Psychiatry. This investigation assessed the psychometric properties of the Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) for the detection of cognitive impairment in BD. Methods After short training, psychiatrists at 40 outpatient clinics administered the SCIP three times over two weeks to a total of 76 consecutive type I BD admissions. Experienced psychologists also administered a comprehensive ba…

AdultMalemedicine.medical_specialtyBipolar DisorderPsychometricsAdolescentPsychometricslcsh:Computer applications to medicine. Medical informaticsAmbulatory Care FacilitiesSensitivity and SpecificityYoung AdultCognitionQuality of lifemedicineManic-depressive illnessOutpatient clinicHumansBipolar disorderPsychiatryTrastorn bipolarResearchNeuropsychologyPublic Health Environmental and Occupational HealthConstruct validityReproducibility of ResultsCognitionGeneral MedicineMiddle Agedmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersLogistic ModelsROC CurveSpainCase-Control StudiesCogniciólcsh:R858-859.7FemalePsicometriaPsychologyCognition DisordersNeurocognitiveClinical psychologyHealth and Quality of Life Outcomes
researchProduct

Bipolar I and Bipolar II Disorder: Cognition and Emotion Processing

2006

Background. Cognitive impairment may be part of the endophenotype of bipolar disorder (BP), but little is known about patterns and severity of impairment in BP subgroups and their relation to depression. The same applies to deficits in emotion processing known to be present in BP.Method. To explore the relationship between depression and impairment in cognition and emotion processing and the differences between BP subgroups, we assessed 36 (25 BP I and 11 BP II) patients using a cognitive battery and a facial emotion recognition task.Results. BP patients were impaired compared to published norms on memory, naming and executive measures (Binomial Single Proportion tests, p<0·05). Cognitiv…

AdultMalemedicine.medical_specialtyBipolar Disordermedicine.medical_treatmentNeuropsychological TestsSeverity of Illness IndexBipolar II disorderElectroconvulsive therapymedicineHumansEffects of sleep deprivation on cognitive performanceBipolar disorderPsychiatryApplied PsychologySettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaCognitive disorderCognitionmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthAffectEndophenotypeFemaleAdult Affect* Bipolar Disorder/diagnosis* Bipolar Disorder/epidemiology* Cognition Disorders/diagnosis Cognition Disorders/epidemiology Diagnostic and Statistical Manual of Mental Disorders Female Humans Male Neuropsychological Tests Severity of Illness Indexmedicine.symptomPsychologyCognition DisordersManiaClinical psychology
researchProduct